000 04135nam a22005655i 4500
001 978-981-97-2954-8
003 DE-He213
005 20251030112244.0
007 cr nn 008mamaa
008 240530s2024 si | s |||| 0|eng d
020 _a9789819729548
_9978-981-97-2954-8
024 7 _a10.1007/978-981-97-2954-8
_2doi
050 4 _aK4240-4343
072 7 _aLNJ
_2bicssc
072 7 _aLAW000000
_2bisacsh
072 7 _aLNJ
_2thema
100 1 _aSharma, Kavita.
_eauthor.
_0(orcid)0000-0001-7262-4494
_1https://orcid.org/0000-0001-7262-4494
_4aut
_4http://id.loc.gov/vocabulary/relators/aut
_977885
245 1 0 _aArtificial Intelligence in Drug Development
_h[electronic resource] :
_bPatenting and Regulatory Aspects /
_cby Kavita Sharma, Padmavati Manchikanti.
250 _a1st ed. 2024.
264 1 _aSingapore :
_bSpringer Nature Singapore :
_bImprint: Springer,
_c2024.
300 _aXIII, 149 p. 35 illus., 33 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aFrontiers of Artificial Intelligence, Ethics and Multidisciplinary Applications,
_x2731-8133
505 0 _aArtificial Intelligence in Drug Development - Nature and Scope -- Analysis of AI Related Patents in the Healthcare -- Regulation of AI in Drug Development -- Policy and Regulation for AI for Indian Drug and Healthcare Industry -- Way forward for Patenting and Regulation in relation to AI.
520 _aThis book discusses how Artificial Intelligence developments have revolutionized the area of medicine and how companies use them to develop applications. While the book covers the growth of AI in medicine and the early developments in AI based medical tools, it provides an in-depth analysis of the current developments in relation to the area of medical diagnostics. The book focuses on how enterprises and institutes have developed their intellectual property portfolio, particularly patents, in this area. Cross-country patenting analysis helps in understanding key areas of growth in certain markets and also company strategies and arrangements. The introduction of AI based products in market is subject to regulation. The developments in policy and regulation influence the development and deployment of such products into the market. This book brings focus to the development of policy and regulation and how regulatory developments impact the introduction of AI-based healthcare products from a cross-country perspective. Further, how regulatory developments lead to the evolution of standards, build reliability and safety in this area are also examined. The unique aspect of this book is the comprehensive coverage of the dual aspects of the nature and scope of AI-based innovations in health care and the related drug regulatory aspects which are imperative for the understanding for students, researchers, and those who work in this area.
650 0 _aInformation technology
_xLaw and legislation.
_967243
650 0 _aMass media
_xLaw and legislation.
_967244
650 0 _aHealth services administration.
_961649
650 0 _aArtificial intelligence.
_958441
650 1 4 _aIT Law, Media Law, Intellectual Property.
_967246
650 2 4 _aHealth Care Management.
_967006
650 2 4 _aArtificial Intelligence.
_958441
700 1 _aManchikanti, Padmavati.
_eauthor.
_4aut
_4http://id.loc.gov/vocabulary/relators/aut
_977886
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9789819729531
776 0 8 _iPrinted edition:
_z9789819729555
776 0 8 _iPrinted edition:
_z9789819729562
830 0 _aFrontiers of Artificial Intelligence, Ethics and Multidisciplinary Applications,
_x2731-8133
_971701
856 4 0 _uhttps://doi.org/10.1007/978-981-97-2954-8
912 _aZDB-2-LCR
912 _aZDB-2-SXLC
999 _c60313
_d60313